Taro Announces Completion of $250 Million Share Repurchase Program

HAWTHORNE, N.Y.--(BUSINESS WIRE)-- Taro Pharmaceutical Industries Ltd. (NYSE: TARO) announced today that it recently completed its $250 million share repurchase program. The company bought back 1,801,099 of its ordinary shares in open market transactions at an average price of $138.80 per share. The repurchase program was announced by the company on March 15, 2016, and was completed on August 18, 2016.

About Taro

Taro Pharmaceutical Industries Ltd. is a multinational, science-based pharmaceutical company, dedicated to meeting the needs of its customers through the discovery, development, manufacturing and marketing of the highest quality healthcare products. For further information on Taro Pharmaceutical Industries Ltd., please visit the Company’s website at www.taro.com.

View source version on businesswire.com: http://www.businesswire.com/news/home/20160819005714/en/

Taro Pharmaceutical Industries Ltd.
William J. Coote, 914-345-9001
[email protected]

Source: Taro Pharmaceutical Industries Ltd.

You May Also Be Interested In

• The Panda Adventure to Air on Two Major Greek TV Channels on Oct. 28
• Building the Institution Before the Scale: How Aarush Garg Is Designing Aarion Capital for Long-Term Growth
• GROWNSY Kicks Off Prime Big Deal Days With One Idea: ONE DAY EARLIER. ONE DAY EASIER.